SPC125

Secúkínúmab

  • Status:
    Veitt
  • Application date:
    6.7.2015
  • Application published:
    15.8.2015
  • Grant published:
    15.3.2017
  • Max expiry date:
    18.7.2030
  • Next due date:
    31.8.2026
  • Medicine name:
    Cosentyx
  • Medicine for children:
    Yes

Timeline

Today
6.7.2015Application
15.8.2015Publication
15.3.2017Registration
4.8.2026Expires

Marketing license

  • IS authorization number:
    EU/1/14/980/001-005
  • Date:
    4.2.2015
  • Foreign authorization number:
    EU/1/14/980
  • Date:
    15.1.2015

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, Basel CH

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 8.8.2025

Expires: 4.8.2026

Payer: Árnason Faktor ehf.

Upload documents